Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited

Abstract

ObjectivesTo evaluate the safety and short-term oncological outcomes of (68)gallium-labelled prostate-specific membrane antigen (Ga-68-PSMA) positron-emission tomography (PET)/computed tomography (CT)-directed robot-assisted salvage node dissection (RASND) for prostate cancer oligometastatic nodal recurrence

Similar works

Full text

thumbnail-image

UQ eSpace (University of Queensland)

redirect
Last time updated on 01/08/2017

This paper was published in UQ eSpace (University of Queensland).

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.